Literature DB >> 10671325

Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors.

M R Krone1, A Wald, S R Tabet, M Paradise, L Corey, C L Celum.   

Abstract

We investigated the frequency, site, and risk factors for herpes simplex virus (HSV) shedding in 30 human immunodeficiency virus (HIV)-negative HSV type 2 (HSV-2)-seropositive men who have sex with men. Subjects collected daily HSV culture samples from genital, perianal, and oral areas for 100 days and maintained diaries of signs and symptoms. Sixteen men (53.3%) shed HSV-2, and 9 (56.3%) of 16 men who were also HSV type 1 (HSV-1)-seropositive shed HSV-1. Overall, HSV-2 was isolated on 3.1% of the days; 68% of the isolations were on days that lesions did not occur. HSV-2 shedding was predominantly perianal (83.3%). HSV-1 was isolated on 2.1% of the days; 23 of 24 HSV-1 isolates were from oral areas. Rates of perianal or genital shedding were 6.6% on the days that participants reported prodromal symptoms and 1.9% on the days that participants did not report prodromal symptoms (P<.001). Men seropositive for both HSV-1 and HSV-2 were significantly more likely to shed HSV-2 (odds ratio, 4.1; 95% confidence interval, 1.4-11.9) than were HSV-2-seropositive men. HSV-2-seropositive men who have sex with men have frequent subclinical HSV-2 shedding, usually from the perianal area, and more frequent prodromal HSV-2 shedding.

Entities:  

Mesh:

Year:  2000        PMID: 10671325     DOI: 10.1086/313647

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  16 in total

Review 1.  Sorting out the new HSV type specific antibody tests.

Authors:  R L Ashley
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

2.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

3.  Development of disease and immunity at the genital epithelium following intrarectal inoculation of male guinea pigs with herpes simplex virus type 2.

Authors:  Nigel Bourne; Brianne N Banasik; Clarice L Perry; Aaron L Miller; Mellodee White; Richard B Pyles; Gregg N Milligan
Journal:  Virology       Date:  2018-11-06       Impact factor: 3.616

4.  Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding.

Authors:  Joshua T Schiffer; Bryan T Mayer; Youyi Fong; David A Swan; Anna Wald
Journal:  J R Soc Interface       Date:  2014-03-26       Impact factor: 4.118

Review 5.  Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision.

Authors:  A Scoular
Journal:  Sex Transm Infect       Date:  2002-06       Impact factor: 3.519

6.  The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation.

Authors:  Moira A McMahon; Janet D Siliciano; Jun Lai; Jun O Liu; James T Stivers; Robert F Siliciano; Rahul M Kohli
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

7.  Overlapping reactivations of herpes simplex virus type 2 in the genital and perianal mucosa.

Authors:  Sunitha Tata; Christine Johnston; Meei-Li Huang; Stacy Selke; Amalia Magaret; Lawrence Corey; Anna Wald
Journal:  J Infect Dis       Date:  2010-02-15       Impact factor: 5.226

8.  Oral shedding of herpes simplex virus type 2.

Authors:  A Wald; M Ericsson; E Krantz; S Selke; L Corey
Journal:  Sex Transm Infect       Date:  2004-08       Impact factor: 3.519

9.  Acute herpetic gingivostomatitis associated with herpes simplex virus 2: report of a case.

Authors:  Annie Kitty George; Sukumaran Anil
Journal:  J Int Oral Health       Date:  2014-06-26

10.  Herpes simplex virus type 2 seroprevalence in Korea: rapid increase of HSV-2 seroprevalence in the 30s in the southern part.

Authors:  Haeng Seop Shin; Jeong Joo Park; Chaeshin Chu; Hyeon Je Song; Kyung Soon Cho; Joo Shil Lee; Sung Soon Kim; Mee Kyung Kee
Journal:  J Korean Med Sci       Date:  2007-12       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.